CAS 2820336-67-0

Formule : C31H29FN4O3S

InChI : InChI=1S/C31H29FN4O3S/c1-35-13-10-21(11-14-35)19-2-4-20(5-3-19)22-6-7-23-18-36(30(39)25(23)16-22)28(26-17-24(32)8-9-27(26)37)29(38)34-31-33-12-15-40-31/h2-9,12,15-17,21,28,37H,10-11,13-14,18H2,1H3,(H,33,34,38)

Code InChI : SYTVDTWRIZNVEW-UHFFFAOYSA-N

SMILES : CN1CCC(CC1)C2=CC=C(C=C2)C3=CC4=C(CN(C4=O)C(C5=C(C=CC(=C5)F)O)C(=O)NC6=NC=CS6)C=C3

2-(5-Fluoro-2-hydroxyphenyl)-2-(6-(4-(1-methylpiperidin-4-yl)phenyl)-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide

CAS : 2820336-67-0

2-(5-Fluoro-2-hydroxyphenyl)-2-(6-(4-(1-methylpiperidin-4-yl)phenyl)-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide

Formule : C₃₁H₂₉FN₄O₃S

Degré de pureté : 98%

Masse moléculaire : 556.65

Ref: 54-PC1027930

2-(5-Fluoro-2-hydroxyphenyl)-2-(6-(4-(1-methylpiperidin-4-yl)phenyl)-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide

CAS : 2820336-67-0

Degré de pureté : 98%

Ref: IN-DA027MKG

JBJ-09-063

CAS : 2820336-67-0

JBJ-09-063: EGFR inhibitor, IC50s 0.147-0.396 nM for various mutants; hinders EGFR/Akt/ERK1/2 phosphorylation; targets TKI-sensitive/resistant lung cancer.

Formule : C₃₁H₂₉FN₄O₃S

Couleur et forme : Solid

Masse moléculaire : 556.65

Ref: TM-T63939